These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3718862)

  • 1. Apparent progression of lentigo maligna to invasive melanoma during treatment with topical azelaic acid.
    McLean DI; Peter KK
    Br J Dermatol; 1986 Jun; 114(6):685-9. PubMed ID: 3718862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dicarboxylic acids on lentigo maligna.
    Nazzaro-Porro M; Passi S; Balus L; Breathnach A; Martin B; Morpurgo G
    J Invest Dermatol; 1979 Jun; 72(6):296-305. PubMed ID: 448162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent lentigo maligna melanoma: regression associated with local azelaic acid 20%.
    Vereecken P; Heenen M
    Int J Clin Pract; 2002; 56(1):68-9. PubMed ID: 11831841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of lentigo maligna with azelaic acid.
    Rodríguez Prieto MA; Manchado Lopez P; Ruiz Gonzalez I; Suarez D
    Int J Dermatol; 1993 May; 32(5):363-4. PubMed ID: 8505164
    [No Abstract]   [Full Text] [Related]  

  • 5. Rapid progression of lentigo maligna to deeply invasive lentigo maligna melanoma. Report of two cases.
    Michalik EE; Fitzpatrick TB; Sober AJ
    Arch Dermatol; 1983 Oct; 119(10):831-5. PubMed ID: 6614952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten years' experience of treating lentigo maligna with topical azelaic acid.
    Nazzaro-Porro M; Passi S; Zina G; Breathnach AS
    Acta Derm Venereol Suppl (Stockh); 1989; 143():49-57. PubMed ID: 2773614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.
    Serban ED; Farnetani F; Pellacani G; Constantin MM
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentigo maligna and malignant melanoma.
    Jackson R; Williamson GS; Beattie WG
    Can Med Assoc J; 1966 Oct; 95(17):846-51. PubMed ID: 5922502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive melanoma in the donor and recipient sites of a Hutchinson's freckle transplanted in a split skin graft.
    McEwan LE; Buchanan MR
    Aust N Z J Surg; 1986 Jan; 56(1):81-4. PubMed ID: 3527133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of DNA synthesis of melanoma cells by azelaic acid.
    Leibl H; Stingl G; Pehamberger H; Korschan H; Konrad K; Wolff K
    J Invest Dermatol; 1985 Nov; 85(5):417-22. PubMed ID: 4056455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conventional radiotherapy in the treatment of lentigo maligna and lentigo maligna melanoma.
    Harwood AR
    J Am Acad Dermatol; 1982 Mar; 6(3):310-6. PubMed ID: 7068960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lentigo maligna: review of salient characteristics and management.
    Kallini JR; Jain SK; Khachemoune A
    Am J Clin Dermatol; 2013 Dec; 14(6):473-80. PubMed ID: 24019181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focus on melanoma: the therapeutic dilemma of lentigo maligna (Hutchinson's freckle).
    Silvers DN
    J Dermatol Surg; 1976 Sep; 2(4):301-3. PubMed ID: 1026731
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluorescence-microscopic investigations of pigment cells of lentigo maligna (melanosis circumscripta praeblastomatosa Dubreuilh) and lentigo maligna melanoma.
    Paul E; Illig L
    Arch Dermatol Res (1975); 1976 Aug; 256(2):179-87. PubMed ID: 962389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentigo maligna and lentigo maligna melanoma in young adults.
    Durnick A; Stolz W; Landthaler M; Vogt T
    Dermatol Surg; 2004 May; 30(5):813-6. PubMed ID: 15099332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Black lesions of the skin.
    BECKER SW
    Calif Med; 1958 Mar; 88(3):228-33. PubMed ID: 13511215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression to invasive melanoma from malignant melanoma in situ, lentigo maligna type.
    Tannous ZS; Lerner LH; Duncan LM; Mihm MC; Flotte TJ
    Hum Pathol; 2000 Jun; 31(6):705-8. PubMed ID: 10872664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelanotic lentigo maligna.
    Burket JM
    Arch Dermatol; 1979 Apr; 115(4):496. PubMed ID: 434879
    [No Abstract]   [Full Text] [Related]  

  • 19. Azelaic acid in lentigo maligna.
    Br J Dermatol; 1987 Apr; 116(4):605-7. PubMed ID: 3580294
    [No Abstract]   [Full Text] [Related]  

  • 20. The risk of progression of lentigo maligna to lentigo maligna melanoma.
    Weinstock MA; Sober AJ
    Br J Dermatol; 1987 Mar; 116(3):303-10. PubMed ID: 3567069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.